AnaptysBio Inc (ANAB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.43B
EV to revenue ratio (TTM)
5.33
EV to ebitda
21.17
Financial Performance
Revenue (TTM)
$0.11B
Gross profit (TTM)
$0.11B
EBITDA
$0.07B
Profitability
Operating margin (TTM)
53.40%
Profit margin
247.00%
Return on assets (TTM)
6.78%
Return on equity (TTM)
-114.50%
Per Share Metrics
Revenue per share (TTM)
$3.66
EPS
-$0.96
Diluted EPS (TTM)
-$0.96
Book value
$0.36
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
19.19
PEG ratio
0
Price to sales ratio (TTM)
13.52
Price to book ratio (TTM)
131.27
Growth
Quarterly earnings growth (YoY)
23.50%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
3
Buy
5
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.37